Number of the records: 1  

alemtuzumab

  1. Subject h.alemtuzumab
    Subject h.Alemtuzumab
    Entry termsprotilátka monoklonálna Campath-1H
    Lemtrada
    Scope note in EnglishAn anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
    See also reference (FX) in Slovak antigén CD52
    See also reference (FX) in English CD52 Antigen
    Links (21) - ARTICLES
    (1) - MeSH descriptor
    (1) - CiBaMed
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all